Evidence map›Paper›PMID 40217127›Full record

ArticleNature microbiology2025

An ISWI-related chromatin remodeller regulates stage-specific gene expression in Toxoplasma gondii.

Belen Pachano, Dayana C Farhat, Martina Shahinas, Jill von Velsen, Charlotte Corrao, Lucid Belmudes, Pieter-Jan de Bock, Caroline Mas, Yohann Couté, Matthew W Bowler and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Belen PachanoInstitute for Advanced Biosciences, University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Grenoble, France.ORCID http://orcid.org/0009-0005-0654-0336
Dayana C FarhatInstitute for Advanced Biosciences, University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Grenoble, France.
Martina ShahinasInstitute for Advanced Biosciences, University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Grenoble, France.ORCID http://orcid.org/0000-0003-1409-6499
Jill von VelsenEuropean Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France.ORCID http://orcid.org/0000-0002-1254-7842
Charlotte CorraoInstitute for Advanced Biosciences, University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Grenoble, France.
Lucid BelmudesUniversity Grenoble Alpes (INSERM, UA13 BGE, CNRS, CEA), Grenoble, France.
Pieter-Jan de BockUniversity Grenoble Alpes (INSERM, UA13 BGE, CNRS, CEA), Grenoble, France.
Caroline MasIntegrated Structural Biology Grenoble, Université Grenoble Alpes, EMBL (CNRS, CEA), Grenoble, France.
Yohann CoutéUniversity Grenoble Alpes (INSERM, UA13 BGE, CNRS, CEA), Grenoble, France.ORCID http://orcid.org/0000-0003-3896-6196
Matthew W BowlerEuropean Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France.ORCID http://orcid.org/0000-0003-0465-3351
Alexandre BougdourInstitute for Advanced Biosciences, University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Grenoble, France.
Christopher Swale *Institute for Advanced Biosciences, University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Grenoble, France. christopher.swale@inserm.fr.ORCID http://orcid.org/0000-0002-9739-7774
Mohamed-Ali Hakimi *Institute for Advanced Biosciences, University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Grenoble, France. mohamed-ali.hakimi@inserm.fr.ORCID http://orcid.org/0000-0002-2547-8233

Funding

Agence Nationale de la Recherche (French National Research Agency) ApiMORCing, ANR-21-CE15-0002-01Agence Nationale de la Recherche (French National Research Agency) ApiNewDrug, ANR-21-CE35-0010-01Agence Nationale de la Recherche (French National Research Agency) Chaires Excellence Biologie Santé ANR-24-CHBS-0008Agence Nationale de la Recherche (French National Research Agency) GRAL (ANR-17-EURE-0003).Agence Nationale de la Recherche (French National Research Agency) ProFI (ANR-10-INBS-08)
6 · The paper itself

Abstract

ATP-dependent chromatin remodellers are specialized multiprotein machines that organize the genome in eukaryotic cells and regulate its accessibility by repositioning, ejecting or modifying nucleosomes. However, their role in Toxoplasma gondii is poorly understood. Here we show that T. gondii has evolved two divergent proteins within the imitation switch (ISWI) family: TgSNF2h and TgSNF2L. TgSNF2h specifically forms a core complex with the transcription factor AP2VIII-2 and the scaffold protein TgRFTS. Depletion of TgRFTS phenocopies the knockdown of TgSNF2h, restricting access to chromatin and altering local gene expression. At the genomic level, TgSNF2h insulates highly transcribed genes from silenced neighbours, ensuring stage-specific gene regulation. By modulating chromatin accessibility to transcription factors, TgSNF2h exerts epistatic control over MORC, a key regulator of sexual commitment. Our findings show that a specific ISWI complex orchestrates the partitioning of developmental genes and ensures transcriptional fidelity throughout the parasite life cycle.

Indexed as

Chromatin Assembly and DisassemblyGene Expression RegulationProtozoan ProteinsToxoplasmaTranscription FactorsChromatinLife Cycle StagesChromatinProtozoan ProteinsTranscription Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.